Jonathan  Hunt

CEO designate

Mr. Jonathan Hunt has been appointed as Chief Executive Officer of the Company, effective April 01 2016. Jonathan has a rich experience in the global biopharmaceutical industry and a proven track record of leading transformational change and delivering growth. He is responsible for strengthening Syngene’s relations with its existing global customers as well as forging new relationships. He will also steer the company’s investments in developing and strengthening its capabilities and capacities to augment Syngene’s service offerings. Prior to Syngene, Jonathan had a long standing association with Astrazeneca where he held various leadership positions including President & Director of Astrazeneca, Austria and President & COO, Astrazeneca India. Earlier in his career he worked with Bayer Schering Pharma in various capacities. He holds a BA (Business Studies & Economics) from the University of Sheffield, UK and an MBA from Durham University, UK.